resources

Zydus Lifesciences Ltd.

NSE: ZYDUSLIFE

BSE: 532321

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

1,124.70-7.8 (-0.69%)

14 Oct, 3:30 PM

Overview Analysis Statements Technicals Forecast Peers Resources

News

Annual Reports and Financial Documents

Zydus Lifesciences Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Annual Reports	FY 2013	FY 2014	FY 2015	FY 2016	FY 2017	FY 2018	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Quarterly Results	—	—	—	—	—	Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun
Conference Calls	—	—	—	—	—	—	—	—	20Aug 3Sept 22Nov	26May 13Aug	10Feb 24May 18Aug 11Nov	14Feb 23May 17Aug 19Nov	11Feb 27May 20Aug 13Nov	15Feb 24May 18Aug
Presentations	—	—	—	—	—	—	—	—	12Jan 24Feb 11Aug 29Oct	3Feb 20May 10Aug 11Nov	3Feb 18May 11Aug 17Sept 7Nov	9Feb 17May 9Aug 27Aug 12Nov	5Feb 11Mar 20May 24Jun 12Aug 6Nov 25Nov	9Feb 19May 11Aug 23Aug

Corporate Announcements and Regulatory Filings

Zydus Lifesciences Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.

Press Release / Media Release13 Oct 2026
Announcement under Regulation 30 (LODR)-Press Release / Media Release
USFDA Inspection
Press Release / Media Release13 Oct 2026
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus and Formycon: FYB206 Becomes First Publicly Announced Keytruda Biosimilar Accepted for Review by UDFDA.
Press Release / Media Release12 Oct 2026
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus Therapeutics Presents New Post Hoc Analysis of Phase 3 EPICS-III Trial at ACG 2026 Showing Greater Biochemical Response With Investigational Saroglitazar Compared to Placebo Across ....
Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20186 Oct 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended on September 30, 2026.
Press Release / Media Release5 Oct 2026
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus, MSN partner to Launch First Generic of Adempas (Riociguat Tablets) in the U.S.
Joint Venture1 Oct 2026
Announcement under Regulation 30 (LODR)-Updates on Joint Venture
Extension of date of closing
Press Release / Media Release28 Sept 2026
Announcement under Regulation 30 (LODR)-Press Release / Media Release
USFDA inspection concludes at Zydus'' manufacturing plant at SEZ II, Ahmedabad.
Closure of Trading Window26 Sept 2026
Closure of Trading Window
Intimation of Trading Window Closure
Press Release / Media Release26 Sept 2026
Announcement under Regulation 30 (LODR)-Press Release / Media Release
USFDA inspection of pharmacovigilance and post marketing system concludes at Zydus'' USA Office with nil observations.
Newspaper Publication24 Sept 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication of Notice of loss of share certificate of the Company, published in the Financial Express English and Gujarati editions, both on September 24, 2026.
Newspaper Publication22 Sept 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication of Notice of opening of Special Window for transfer and dematerialization of physical securities, published in the Financial Express English and Gujarati editions, ....
Credit Rating11 Sept 2026
Announcement under Regulation 30 (LODR)-Credit Rating
Credit Rating
Analyst / Investor Meet11 Sept 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
The Company is going to participate in J.P. Morgan India Conference, 2026, on September 21, 2026.
Newspaper Publication9 Sept 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication of Notice of loss of share certificate of the Company, published in the Financial Express English and Gujarati editions, both on September 9, 2026.
General5 Sept 2026
Settlement Agreement
Settlement Agreement
AGM1 Sept 2026
Transcript Of The 31St Annual General Meeting
Transcript of the 31st Annual General Meeting
Press Release / Media Release31 Aug 2026
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus Announces Positive Topline Results from Completed EVIDENCES-X Phase II(b) Clinical Trial of Saroglitazar Mg in MASH.
General26 Aug 2026
Incorporation Of A Wholly Owned Subsidiary In Gift City, Gandhinagar, Gujarat
Incorporation of a wholly owned subsidiary in Gift City, Gandhinagar, Gujarat
General25 Aug 2026
ESG Rating
ESG Rating
General24 Aug 2026
Disclosure Under SEBI (Prohibition Of Insider Trading) Regulations, 2015
Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015

Frequently Asked Questions

Where can I download the annual report of Zydus Lifesciences Ltd.?

Annual reports of Zydus Lifesciences Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.

Where can I find the quarterly results of Zydus Lifesciences Ltd.?

Quarterly earnings results and presentations of Zydus Lifesciences Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.

Does Zydus Lifesciences Ltd. publish earnings call transcripts?

Earnings call transcripts of Zydus Lifesciences Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.

Where can I find investor presentations of Zydus Lifesciences Ltd.?

Investor presentations and annual day presentations of Zydus Lifesciences Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.

What are the recent corporate announcements of Zydus Lifesciences Ltd.?

Corporate announcements and regulatory filings of Zydus Lifesciences Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.

How do I access the regulatory filings of Zydus Lifesciences Ltd.?

Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Zydus Lifesciences Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.

What is the ISIN of Zydus Lifesciences Ltd.?

The ISIN (International Securities Identification Number) of Zydus Lifesciences Ltd. is INE010B01027. This is the unique identifier used across exchanges and depositories.

On which stock exchange is Zydus Lifesciences Ltd. listed?

Zydus Lifesciences Ltd. is listed on NSE and BSE. The NSE symbol is ZYDUSLIFE and the BSE code is -.

Where can I find the shareholding pattern of Zydus Lifesciences Ltd.?

The quarterly shareholding pattern of Zydus Lifesciences Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.

How current is the data for Zydus Lifesciences Ltd. on Sharpely?

Share price data for Zydus Lifesciences Ltd. is updated as of 14 Oct 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.